CY1116202T1 - UNIONS CONTAINING BATHROOM AS SUSPENSIONS OF CRYSTAL PROPERTIES - Google Patents

UNIONS CONTAINING BATHROOM AS SUSPENSIONS OF CRYSTAL PROPERTIES

Info

Publication number
CY1116202T1
CY1116202T1 CY20151100358T CY151100358T CY1116202T1 CY 1116202 T1 CY1116202 T1 CY 1116202T1 CY 20151100358 T CY20151100358 T CY 20151100358T CY 151100358 T CY151100358 T CY 151100358T CY 1116202 T1 CY1116202 T1 CY 1116202T1
Authority
CY
Cyprus
Prior art keywords
suspensions
crystal properties
unions
bathroom
containing bathroom
Prior art date
Application number
CY20151100358T
Other languages
Greek (el)
Inventor
John O Link
Craig J Mossman
Jie Liu
Soon Hyung Woo
Original Assignee
Virobay, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP07853752.9A external-priority patent/EP2079683B1/en
Application filed by Virobay, Inc. filed Critical Virobay, Inc.
Publication of CY1116202T1 publication Critical patent/CY1116202T1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Η παρούσα εφεύρεση αφορά ενώσεις οι οποίες είναι αναστολείς των κυστεϊνικών πρωτεάσεων, ειδικότερα των καθεψινών Β, Κ, L, F, και S, και συνεπώς είναι χρήσιμες στη θεραπεία νόσων μεσολαβούμενων από αυτές τις πρωτεάσες. Η παρούσα εφεύρεση αφορά φαρμακευτικές συνθέσεις οι οποίες περιέχουν τις ενώσεις αυτές και διαδικασίες για την παρασκευή τους.The present invention relates to compounds which are inhibitors of cysteine proteases, in particular cathepsins B, K, L, F, and S, and are therefore useful in the treatment of diseases mediated by these proteases. The present invention relates to pharmaceutical compositions containing these compounds and processes for their preparation.

CY20151100358T 2006-10-04 2015-04-17 UNIONS CONTAINING BATHROOM AS SUSPENSIONS OF CRYSTAL PROPERTIES CY1116202T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84958706A 2006-10-04 2006-10-04
EP07853752.9A EP2079683B1 (en) 2006-10-04 2007-10-03 Di-fluoro containing compounds as cysteine protease inhibitors

Publications (1)

Publication Number Publication Date
CY1116202T1 true CY1116202T1 (en) 2017-02-08

Family

ID=58457939

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151100358T CY1116202T1 (en) 2006-10-04 2015-04-17 UNIONS CONTAINING BATHROOM AS SUSPENSIONS OF CRYSTAL PROPERTIES

Country Status (1)

Country Link
CY (1) CY1116202T1 (en)

Similar Documents

Publication Publication Date Title
CY1119669T1 (en) DERIVATIVES OF 1-PHENYL-2-PYRIDINYL-ALKYL-ALCOHOL AS PHOSPHOesterase Inhibitors
DK1853602T3 (en) Chemical compounds
DK1853588T3 (en) Chemical compounds
CY1114075T1 (en) KETOAMIDE ALPHA UNIONS AS CYSTINE PROTEIN INHIBITORS
NO20082594L (en) Pyrimidinylbenzotiofenforbindelser
EA201070247A1 (en) PROTEAS INHIBITORS
NO20074823L (en) Rasagilin formulations with improved content uniformity
NO20060230L (en) Novel aminobenzophenone compounds
NO20090628L (en) Pyridizinone derivatives
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
NO20061627L (en) Haloalkyl containing compounds as cysteine protease inhibitors
WO2007097981A3 (en) Alpha carbolines and uses thereof
CL2007000789A1 (en) Malonamide derived compounds, gamma-secretase inhibitors; Preparation process; pharmaceutical composition; and its use in the treatment of Alzheimer's disease.
TW200621260A (en) Selected fused heterocyclics and uses thereof
MX2007011739A (en) Sulfonyl containing compounds as cysteine protease inhibitors.
EA200801211A1 (en) DERIVATIVES 9-CHLOR-15-PROSTAGLANDINA, METHOD FOR THEIR PRODUCTION AND USE IN DRUGS
IL189286A0 (en) Novel cysteine protease inhibitors and their therapeutic applications
EA200900510A1 (en) DIFFLUOROSODERSTATING COMPOUNDS AS INHIBITORS OF CYTEIN PROTEAS
MX2008007195A (en) Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications.
ATE496899T1 (en) TETRAHYDRO- AND DIHYDROQUINAZOLINONES
CY1116202T1 (en) UNIONS CONTAINING BATHROOM AS SUSPENSIONS OF CRYSTAL PROPERTIES
UA95930C2 (en) Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
MY148355A (en) Crystal form of epothilone b and use in pharmaceutical compositions
UA95260C2 (en) 4-(3-aminopyrazole) pyrimidine derivative and use thereof in the treatment of cancer
UA93198C2 (en) Pyrazole derivatives, process for the preparation and use thereof, pharmaceutical compositions and methods for the treatment of cancer